Scope
The Bottom Line
- Characterise whether fear peaks abruptly or persists over months, the physical and cognitive symptoms, triggers, avoidance, functional effect and recurrence rather than applying the label anxiety to undifferentiated distress.
- Check observations, oxygenation and bedside glucose when indicated and investigate chest pain, dyspnoea, syncope, arrhythmia, endocrine disease, intoxication, withdrawal and medicine effects before assuming a primary panic disorder.
- During a panic attack, remain with the person in a calm environment, explain what is being assessed and use paced breathing or grounding without dismissing symptoms or repeatedly promising that serious disease is impossible.
- Assess trauma, depression, other mental illness, substance use, social stress, pregnancy or postpartum context and the person’s ability to work, study, care for dependants and remain safe.
- For recurrent or functionally important symptoms, arrange local medical and mental-health review, including access to evidence-based psychotherapy; the Queensland source does not justify indefinite sedative prescribing.
Practical clinical workflow
Safety boundaries and escalation
- Ongoing chest pain, hypoxia, syncope, focal neurology, severe headache, haemodynamic abnormality or a presentation inconsistent with previous panic requires urgent physical assessment.
- Suicidal intent, psychosis, mania, severe intoxication or withdrawal, inability to care for self or a child, or rapidly collapsing function requires urgent mental-health or emergency care.
- Pregnancy and postpartum anxiety can coexist with depression, psychosis or intrusive thoughts about infant harm and requires the jurisdiction’s perinatal pathway rather than generic reassurance.
- Sedative medicine can impair breathing, coordination and driving and create dependence; this source set supplies no national repeat-prescribing regimen, so any use requires current product information and a defined review plan.
Implementation
Clinical use boundary
This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Queensland Health and Royal Flying Doctor Service Queensland SectionPrimary Clinical Care Manual, 12th edition: Anxiety and panic attack — adult/childISBN 978-1-876560-22-5 · 12th edition 2025, v1.03 with updates through 21 July 2026; section 5, printed pages 344–346 · accessed 2026-08-20view source
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.